1. Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma
   Dong-Xu Liu et al, 2024, Technology and Health Care CrossRef
2. Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
   Janneta R. Tcherkassova et al, 2023, Consilium Medicum CrossRef
3. Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response
   Lawrence L. Leung et al, 2023, Cancers CrossRef
4. circIARS: a potential plasma biomarker for diagnosing non-small cell lung cancer
   Qi Zhang et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
5. Evaluation of albumin and lactate dehydrogenase in comparison with cytokeratin 19 fragments and neuron‐specific enolase as diagnostic biomarkers for non‐small cell lung cancer
   Xiaodong Feng et al, 2024, iLABMED CrossRef
6. Exhaled Aldehydes as Biomarkers for Lung Diseases: A Narrative Review
   Maximilian Alexander Floss et al, 2022, Molecules CrossRef
7. Osteopontin in Cancer: Mechanisms and Therapeutic Targets
   Yoshinobu Kariya et al, 2022, International Journal of Translational Medicine CrossRef
8. Clinical Value on Combined Detection of Serum CA724, DKK1, and TK1 in Diagnosis of Gastric Cancer
   Yu Wang et al, 2022, Journal of Oncology CrossRef
9. Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker
   Xi Yan et al, 2022, Heliyon CrossRef
10. Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials
    Janneta R. Tcherkassova et al, 2023, Journal of Modern Oncology CrossRef